Hearing · house
"Profits Over Patients: The PBM Business Model Under Scrutiny"
2026-04-22 · 14:15
Source status: Scheduled
Committee
Location
2175, Rayburn House Office Building
Video
Witnesses
Mr. James Gelfand
President and CEO, The ERISA Industry Committee (ERIC)
Mrs. Chris Deacon
Principal and Founder, VerSan Consulting
Ms. Mariana Socal
Associate Professor, Johns Hopkins Bloomberg School of Public Health
Ms. Hannah Anderson
Director, Healthy America Policy and Senior Director of Policy, America First Policy Institute
Documents
Witness documents
- Witness Biography · PDF
- Witness Biography · PDF
- Witness Biography · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Truth in Testimony · PDF
- Witness Truth in Testimony · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Statement · PDF
- Witness Statement · PDF
- Witness Statement · PDF
Committee activity
- Ranking Member Mark DeSaulnier | Submission for the Record | NMSS Statement · Support Document · PDF
- Chairman Rick W. Allen | Submission for the Record | Support Letter for H.R. 7895 · Support Document · PDF
- Chairman Rick W. Allen | Submission for the Record | NAM Letter · Support Document · PDF
- Rep. Tim Walberg | Submission for the Record | Cystic Fibrosis Foundation Support Letter · Support Document · PDF
- Chairman Rick W. Allen | Submission for the Record | Association for Accessible Medicines Letter · Support Document · PDF
- Hearing Notice · Support Document · PDF
- Rep. Tim Walberg | Submission for the Record | American Pharmacists Association Letter · Support Document · PDF
- Rep. Tim Walberg | Submission for the Record | NABIP Statement · Support Document · PDF
- Chairman Rick W. Allen | Submission for the Record | NFIB Letter · Support Document · PDF
Source: https://api.congress.gov/v3/committee-meeting/119/house/119202